Diffuse Aggressive Histologies of Non-Hodgkin Lymphoma: Treatment and Biology of Limited Disease
Data up to Jan 2025
Total Citations Per Year
Abstract
References (31)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
2000 • 9,712 citations
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
2002 • 5,269 citations
World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues
2002 • 4,781 citations
A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
1993 • 4,650 citations
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
2002 • 3,769 citations
WHO-EORTC classification for cutaneous lymphomas
2005 • 3,617 citations
A predictive model for aggressive non-Hodgkin's lymphoma
1993 • 3,483 citations
Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma
2003 • 1,080 citations
Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's Lymphoma
1998 • 1,010 citations
Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia
2005 • 958 citations
The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma
2003 • 843 citations
Patterns of Outcome and Prognostic Factors in Primary Large-Cell Lymphoma of the Testis in a Survey by the International Extranodal Lymphoma Study Group
2002 • 428 citations
Chemotherapy With or Without Radiotherapy in Limited-Stage Diffuse Aggressive Non-Hodgkin's Lymphoma: Eastern Cooperative Oncology Group Study 1484
2004 • 350 citations
ACVBP versus CHOP plus Radiotherapy for Localized Aggressive Lymphoma
2005 • 322 citations
Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project
2004 • 321 citations
Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling
2004 • 286 citations
Utility of Fine-Needle Aspiration As a Diagnostic Technique in Lymphoma
2004 • 275 citations
Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites
2000 • 197 citations
WHO Classification of Tumours: Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues
2003 • 154 citations
Brief Chemotherapy and Involved-Region Irradiation for Limited-Stage Diffuse Large-Cell Lymphoma: An 18-Year Experience From the British Columbia Cancer Agency
2002 • 111 citations
PET Scans in the Staging of Lymphoma: Current Status
2003 • 99 citations
CHEMOTHERAPY OF LOCALISED HISTIOCYTIC LYMPHOMA
1979 • 72 citations
Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.
2000 • 68 citations
Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B‐cell lymphomas of the testis and the central nervous system
2002 • 64 citations
Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: relationship to HLA expression and host immunocompetence.
1993 • 49 citations
T lymphocytes from invaded lymph nodes in patients with B-cell-derived non-Hodgkin's lymphoma: reactivity toward the malignant clone
1990 • 48 citations
Mutations in the HLA class�II genes leading to loss of expression of HLA-DR and HLA-DQ in diffuse large B-cell lymphoma
2003 • 38 citations
Effect of Adding Rituximab to Three Cycles of CHOP Plus Invoved-Field Radiotherapy for Limited-Stage Aggressive Diffuse B-Cell Lymphoma (SWOG-0014).
2004 • 37 citations
No Role for Chemoradiotherapy When Compared with Chemotherapy Alone in Elderly Patients with Localized Low Risk Aggressive Lymphoma: Final Results of the LNH93-4 GELA Study.
2005 • 25 citations
Histologic Subtypes Do Not Confer Unique Outcomes in Early-Stage Lymphoma: Long-Term Follow-Up of SWOG 8736.
2004 • 6 citations
A comparative study of cobalamin deficiency in African Americans with and without sickle cell disease
2003 • 3 citations
Cited By (0)
No citing papers found in database